The role of the cerebellum in schizophrenia: from cognition to molecular pathways
暂无分享,去创建一个
[1] T. Rangaswamy,et al. Course and outcome of schizophrenia , 2012, International review of psychiatry.
[2] M. Phillips,et al. Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication , 2011, Journal of psychopharmacology.
[3] P. Falkai,et al. A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[4] Peter Falkai,et al. Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. , 2010, Journal of psychiatric research.
[5] M. Rietschel,et al. Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[6] P. Falkai,et al. Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[7] I. Hanbauer,et al. Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression , 2010, Proceedings of the National Academy of Sciences.
[8] N. Perrone-Bizzozero,et al. Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine , 2009, Neurochemistry International.
[9] I. Henseler,et al. A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia , 2009, The European journal of neuroscience.
[10] Charlton Cheung,et al. A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia , 2009, Psychopharmacology.
[11] Peter Falkai,et al. Pathological amygdala activation during working memory performance: Evidence for a pathophysiological trait marker in bipolar affective disorder , 2009, Human brain mapping.
[12] M. Rietschel,et al. Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia , 2009, European Archives of Psychiatry and Clinical Neuroscience.
[13] J. Sweeney,et al. An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia , 2009, Psychiatry Research: Neuroimaging.
[14] T. Schneider-Axmann,et al. Stereologic investigation of the posterior part of the hippocampus in schizophrenia , 2009, Acta Neuropathologica.
[15] T. Schneider-Axmann,et al. Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia , 2009, European Archives of Psychiatry and Clinical Neuroscience.
[16] Tilo Kircher,et al. Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas , 2009, European Archives of Psychiatry and Clinical Neuroscience.
[17] P. Falkai,et al. Von der Identifizierung neurofunktioneller Systeme zur Individualisierung der Therapie schizophrener Störungen , 2009, Der Nervenarzt.
[18] M. Keshavan,et al. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia , 2008, Psychiatry Research: Neuroimaging.
[19] Juan Bustillo,et al. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. , 2008, The American journal of psychiatry.
[20] P. Falkai,et al. Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies , 2008, European Archives of Psychiatry and Clinical Neuroscience.
[21] T. Schneider-Axmann,et al. Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. , 2008, Journal of psychiatric research.
[22] G. Kirov,et al. Support for Neuregulin 1 as a Susceptibility Gene for Bipolar Disorder and Schizophrenia , 2008, Biological Psychiatry.
[23] E. Bramon,et al. Neuregulin-1 and the P300 waveform—A preliminary association study using a psychosis endophenotype , 2008, Schizophrenia Research.
[24] N. Andreasen,et al. The Role of the Cerebellum in Schizophrenia , 2008, Biological Psychiatry.
[25] N. Andreasen,et al. Theory of mind and schizophrenia: a positron emission tomography study of medication-free patients. , 2008, Schizophrenia bulletin.
[26] M. Essig,et al. Neurological soft signs and brain morphology in first-episode schizophrenia , 2008, Psychological Medicine.
[27] Peter Mariën,et al. Cerebellar cognitive affective syndrome associated with topiramate , 2008, Clinical Neurology and Neurosurgery.
[28] Peter Stoeter,et al. Association of 5′ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans , 2008, NeuroImage.
[29] T. Lehtimäki,et al. Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia , 2007, European Archives of Psychiatry and Clinical Neuroscience.
[30] Marie-Odile Krebs,et al. The Role of the Cerebellum in Schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences , 2007, Schizophrenia bulletin.
[31] Daniel R. Weinberger,et al. Neuregulin 1 Transcripts Are Differentially Expressed in Schizophrenia and Regulated by 5′ SNPs Associated With the Disease , 2006 .
[32] Peter Falkai,et al. Neural mechanisms of advance preparation in task switching , 2006, NeuroImage.
[33] Paul J. Harrison,et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] L. DeLisi,et al. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia , 2005, Schizophrenia Research.
[35] P. Falkai,et al. Articulatory rehearsal in verbal working memory: A possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder , 2005, Neuroscience Letters.
[36] Sidney H Kennedy,et al. Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? , 2005, Journal of psychiatry & neuroscience : JPN.
[37] Gabriele Ende,et al. Further evidence for altered cerebellar neuronal integrity in schizophrenia. , 2005, The American journal of psychiatry.
[38] Paul J. Harrison,et al. Erratum: Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence (Molecular Psychiatry (2005) 10 (40-68) DOI:10.1038/sj.mp.4001558)) , 2005 .
[39] D. Weinberger,et al. Remission in schizophrenia: proposed criteria and rationale for consensus. , 2005, The American journal of psychiatry.
[40] P. Falkai,et al. [Neural correlates of working memory deficits in schizophrenic patients. Ways to establish neurocognitive endophenotypes of psychiatric disorders]. , 2005, Der Radiologe.
[41] S. Fatemi,et al. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum , 2005, Schizophrenia Research.
[42] R. Kahn,et al. Neuregulin 1: genetic support for schizophrenia subtypes , 2004, Molecular Psychiatry.
[43] T. Lehtimäki,et al. Neuregulin genotype and medication response in Finnish patients with schizophrenia , 2004, Neuroreport.
[44] D. Yves von Cramon,et al. The functional neuroanatomy of human working memory revisited Evidence from 3-T fMRI studies using classical domain-specific interference tasks , 2003, NeuroImage.
[45] Philip D. Harvey,et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.
[46] D. Braus,et al. Effects of Long-Term Antipsychotic Treatment on NMDA Receptor Binding and Gene Expression of Subunits , 2003, Neurochemical Research.
[47] M. Albus,et al. A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia , 2002, European Archives of Psychiatry and Clinical Neuroscience.
[48] H. Stefánsson,et al. Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.
[49] J. Lieberman,et al. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder , 2002, Schizophrenia Research.
[50] N. Andreasen,et al. Selective reduction of the posterior superior vermis in men with chronic schizophrenia , 2002, Schizophrenia Research.
[51] Peter Falkai,et al. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. , 2002, Cerebral cortex.
[52] D. Braus,et al. Lateralized organization of the cerebellum in a silent verbal fluency task: a functional magnetic resonance imaging study in healthy volunteers , 2002, Neuroscience Letters.
[53] O. Gruber. Effects of domain-specific interference on brain activation associated with verbal working memory task performance. , 2001, Cerebral cortex.
[54] N. Schuff,et al. Evidence for altered cerebellar vermis neuronal integrity in schizophrenia , 2001, Psychiatry Research: Neuroimaging.
[55] Paul J. Harrison,et al. Cerebellar synaptic protein expression in schizophrenia , 2001, Neuroscience.
[56] H. Tost,et al. [Current overview of structural magnetic resonance imaging in schizophrenia]. , 2001, Fortschritte der Neurologie-Psychiatrie.
[57] Yoshiro Okubo,et al. Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia , 2001, Biological Psychiatry.
[58] Christian Gaser,et al. Supporting evidence for the model of cognitive dysmetria in schizophrenia — a structural magnetic resonance imaging study using deformation-based morphometry , 2000, Schizophrenia Research.
[59] G. Thaker,et al. Saccadic eye movement abnormalities in relatives of patients with schizophrenia , 2000, Schizophrenia Research.
[60] A. Guidotti,et al. New Neurochemical Markers for Psychosis: A Working Hypothesis of Their Operation , 2000, Neurochemical Research.
[61] Paul J. Harrison,et al. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs , 2000, Molecular Psychiatry.
[62] T. Wassink,et al. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms , 1999, Biological Psychiatry.
[63] R. Roth,et al. The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia , 1999, Neuropsychopharmacology.
[64] Stuart G. Cull-Candy,et al. NMDA receptor diversity in the cerebellum: identification of subunits contributing to functional receptors , 1998, Neuropharmacology.
[65] J. Penney,et al. Cellular Distribution of NMDA Glutamate Receptor Subunit mRNAs in the Human Cerebellum , 1997, Neurobiology of Disease.
[66] Michael Sasner,et al. Neuregulin-β induces expression of an NMDA-receptor subunit , 1997, Nature.
[67] L. Glantz,et al. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.
[68] Alan D. Lopez,et al. Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.
[69] P. Roland,et al. Activation of Multi‐modal Cortical Areas Underlies Short‐term Memory , 1996, The European journal of neuroscience.
[70] W. Faustman,et al. A neuropsychological study of early onset schizophrenia , 1996, Schizophrenia Research.
[71] J. Bower,et al. Cerebellum Implicated in Sensory Acquisition and Discrimination Rather Than Motor Control , 1996, Science.
[72] Daniel R Weinberger,et al. On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia , 1996, Neuropsychopharmacology.
[73] S. Potkin,et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[74] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[75] Leslie G. Ungerleider,et al. Discrete Cortical Regions Associated with Knowledge of Color and Knowledge of Action , 1995, Science.
[76] A. Carlsson. Neurocircuitries and neurotransmitter interactions in schizophrenia , 1995, International clinical psychopharmacology.
[77] German E Berrios,et al. The Cambridge Neurological Inventory: A clinical instrument for assessment of soft neurological signs in psychiatric patients , 1995, Psychiatry Research.
[78] P. Strick,et al. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. , 1994, Science.
[79] J. Ehrhardt,et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. , 1994, Science.
[80] J Townsend,et al. Impairment in shifting attention in autistic and cerebellar patients. , 1994, Behavioral neuroscience.
[81] P. Strick,et al. Activation of a cerebellar output nucleus during cognitive processing. , 1994, Science.
[82] B. Sakmann,et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.
[83] K. Moriyoshi,et al. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. , 1993, The Journal of biological chemistry.
[84] Karl J. Friston,et al. Functional mapping of brain areas implicated in auditory--verbal memory function. , 1993, Brain : a journal of neurology.
[85] E. Courchesne,et al. A new role for the cerebellum in cognitive operations. , 1992, Behavioral neuroscience.
[86] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[87] N C Andreasen,et al. Negative symptoms in schizophrenia , 1982 .
[88] T. Crow,et al. Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.
[89] J. A. Robinson. Clinics , 1883, The Dental register.
[90] Firas H. Kobeissy,et al. Psychiatric Disorders , 2012, Methods in Molecular Biology.
[91] Julie A. Fiez,et al. Cerebellar contributions to verbal working memory: beyond cognitive theory , 2008, The Cerebellum.
[92] Marco Molinari,et al. Cerebellar information processing and visuospatial functions , 2008, The Cerebellum.
[93] W. T. Thach. On the mechanism of cerebellar contributions to cognition , 2008, The Cerebellum.
[94] Peter Thier,et al. The attentive cerebellum — myth or reality? , 2008, The Cerebellum.
[95] Christian Bellebaum,et al. Cerebellar involvement in executive control , 2008, The Cerebellum.
[96] A. Bastian,et al. ‘Motor cognition’ — what is it and is the cerebellum involved? , 2008, The Cerebellum.
[97] Hermann Ackermann,et al. The contribution of the cerebellum to speech production and speech perception: Clinical and functional imaging data , 2008, The Cerebellum.
[98] Paul J. Harrison,et al. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.
[99] Hongyan Zhang,et al. Association study of neuregulin 1 gene with schizophrenia , 2003, Molecular Psychiatry.
[100] H. Stefánsson,et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.
[101] D. Javitt,et al. Are glycine sites saturated in vivo? , 2000, Archives of general psychiatry.
[102] J. Newcomer,et al. Glycine agonists: what can they teach us about schizophrenia? , 1999, Archives of general psychiatry.
[103] A. Carlsson,et al. Neurotransmitter interactions in schizophrenia-therapeutic implications , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[104] M. Ozaki,et al. Neuregulin-beta induces expression of an NMDA-receptor subunit. , 1997, Nature.
[105] N. Akshoomoff,et al. A model system for the study of attention and the cerebellum: infantile autism. , 1995, Electroencephalography and clinical neurophysiology. Supplement.
[106] N. Mendell,et al. Eye tracking and schizophrenia: a selective review. , 1994, Schizophrenia bulletin.
[107] R. Buchanan,et al. Significance and meaning of neurological signs in schizophrenia. , 1988, The American journal of psychiatry.
[108] Heinrichs Dw,et al. Significance and meaning of neurological signs in schizophrenia. , 1988 .